Ratings by Stifel (Paul Matteis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2024 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2024 | Alto Neuroscience | ANRO | New Coverage | Buy (N/A) |
13.72 (14.13) |
2.99% | Details | |
| 1/5/2024 | Neurogene | NGNE | New Coverage | Buy (N/A) |
19.57 (29.87) |
52.63% | Details | |
| 12/18/2023 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Sage Therapeutics | SAGE | Maintain | Hold (N/A) |
|
Details | ||
| 12/18/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 12/18/2023 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 12/18/2023 | Cerevel Therapeutics | CERE | Downgrade | Hold (Buy) |
41.22 (42.07) |
2.06% | Details | |
| 12/13/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Lexeo Therapeutics | LXEO | New Coverage | Buy (N/A) |
11.30 (12.16) |
7.61% | Details | |
| 11/7/2023 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2023 | Neumora Therapeutics | NMRA | New Coverage | Buy (N/A) |
12.14 (9.06) |
-25.37% | Details | |
| 8/7/2023 | Sage Therapeutics | SAGE | Downgrade | Hold (Buy) |
36.10 (13.58) |
-62.38% | Details | |
| 8/3/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 8/1/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2023 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 6/6/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/22/2023 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 3/7/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2023 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2023 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2023 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 12/14/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Hold (N/A) |
|
Details | ||
| 11/14/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Biogen | BIIB | Upgrade | Buy (Buy) |
282.31 (202.46) |
-28.28% | Details | |
| 11/3/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2022 | Biogen | BIIB | Upgrade | Hold (Buy) |
253.67 (282.31) |
11.29% | Details | |
| 10/13/2022 | Biogen | BIIB | Upgrade | Buy (Hold) |
254.07 (202.46) |
-20.31% | Details | |
| 9/12/2022 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2022 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 8/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (Buy) |
|
Details | ||
| 8/3/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 7/27/2022 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 7/22/2022 | Eliem Therapeutics Inc. | ELYM | Maintain | Buy (Buy) |
|
Details | ||
| 7/20/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Biogen | BIIB | Maintain | Hold (Hold) |
|
Details | ||
| 7/19/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Hold (Hold) |
|
Details | ||
| 7/13/2022 | Ionis Pharmaceuticals | IONS | Maintain | Hold (Hold) |
|
Details | ||
| 7/12/2022 | Dyne Therapeutics | DYN | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2022 | Vertex | VRTX | Maintain | Hold (Hold) |
|
Details | ||
| 6/24/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2022 | Athira Pharma | ATHA | Downgrade | Hold (Buy) |
2.85 (1.92) |
-32.63% | Details | |
| 6/22/2022 | Athira Pharma | ATHA | Maintain | Buy (Buy) |
|
Details | ||
| 6/21/2022 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 6/15/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 6/8/2022 | Ionis Pharmaceuticals | IONS | Maintain | Hold (Hold) |
|
Details | ||
| 6/7/2022 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 6/1/2022 | SAGE Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 5/31/2022 | PepGen Inc. | PEPG | New Coverage | Buy (N/A) |
10.30 (11.70) |
13.59% | Details | |
| 5/26/2022 | Avadel Pharmaceuticals | AVDL | Downgrade | Hold (Buy) |
3.38 (17.82) |
427.22% | Details | |
| 5/25/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/12/2022 | WAVE Life Sciences | WVE | Maintain | Hold (Hold) |
|
Details | ||
| 5/9/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 5/5/2022 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2022 | Ionis Pharmaceuticals | IONS | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2022 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Biogen | BIIB | Maintain | Hold (Hold) |
|
Details | ||
| 4/27/2022 | Alkermes | ALKS | Maintain | Hold (Hold) |
|
Details | ||
| 4/27/2022 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 4/25/2022 | Eliem Therapeutics Inc. | ELYM | Maintain | Buy (Buy) |
|
Details | ||
| 4/19/2022 | Athira Pharma | ATHA | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Eliem Therapeutics Inc. | ELYM | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2022 | Biogen | BIIB | Maintain | Hold (Hold) |
|
Details | ||
| 4/4/2022 | WAVE Life Sciences | WVE | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Vertex | VRTX | Maintain | Hold (Hold) |
|
Details | ||
| 3/17/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2022 | Dyne Therapeutics | DYN | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Biogen | BIIB | Downgrade | Hold (Buy) |
209.45 (254.07) |
21.3% | Details | |
| 3/3/2022 | WAVE Life Sciences | WVE | Maintain | Hold (N/A) |
|
Details | ||
| 3/2/2022 | Xenon Pharmaceuticals | XENE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Cerevel Therapeutics | CERE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (Hold) |
|
Details | ||
| 2/28/2022 | Gemini Therapeutics Inc. | GMTX | Downgrade | Hold (Buy) |
1.43 (1.35) |
-5.59% | Details | |
| 2/25/2022 | Ionis Pharmaceuticals | IONS | Maintain | Hold (Hold) |
|
Details | ||
| 2/24/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 2/24/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Eliem Therapeutics Inc. | ELYM | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Alkermes | ALKS | Maintain | Hold (Hold) |
|
Details | ||
| 2/16/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Cerevel Therapeutics | CERE | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2022 | Vigil Neuroscience Inc | VIGL | New Coverage | Buy (N/A) |
14.65 (2.58) |
-82.39% | Details | |
| 1/27/2022 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 11/19/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2021 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 10/14/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2021 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | Vertex | VRTX | Downgrade | Hold (Buy) |
192.20 (397.70) |
106.92% | Details | |
| 9/9/2021 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Buy (Hold) |
77.81 (82.17) |
5.6% | Details | |
| 9/7/2021 | Eliem Therapeutics Inc. | ELYM | New Coverage | Buy (N/A) |
27.35 (3.39) |
-87.61% | Details | |
| 8/6/2021 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 8/3/2021 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Hold (N/A) |
|
Details | ||
| 7/28/2021 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 7/26/2021 | Acumen Pharmaceuticals, Inc. | ABOS | New Coverage | Buy (N/A) |
17.13 (3.19) |
-81.38% | Details | |
| 7/22/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2021 | GH Research PLC | GHRS | New Coverage | Buy (N/A) |
17.50 (10.50) |
-40% | Details | |
| 7/13/2021 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | WAVE Life Sciences | WVE | Maintain | Hold (N/A) |
|
Details | ||
| 4/26/2021 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Hold (Buy) |
48.98 (16.31) |
-66.7% | Details | |
| 2/25/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Gemini Therapeutics Inc. | GMTX | New Coverage | Buy (N/A) |
12.75 (1.43) |
-88.78% | Details | |
| 2/11/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2021 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2021 | Biogen | BIIB | Upgrade | Buy (Hold) |
267.87 (202.46) |
-24.42% | Details | |
| 12/17/2020 | Prevail Therapeutics | PRVL | Downgrade | Hold (Buy) |
22.75 (23.00) |
1.1% | Details | |
| 11/9/2020 | WAVE Life Sciences | WVE | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2020 | Ceres | CERE | New Coverage | Buy (N/A) |
9.82 (42.07) |
328.41% | Details | |
| 11/5/2020 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2020 | GW Pharma | GWPH | Maintain | Hold (N/A) |
|
Details | ||
| 10/30/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2020 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2020 | Athira Pharma | ATHA | New Coverage | Buy (N/A) |
16.81 (1.92) |
-88.58% | Details | |
| 10/12/2020 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
18.99 (23.70) |
24.8% | Details | |
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Downgrade | Hold (Buy) |
118.54 (82.17) |
-30.68% | Details | |
| 8/7/2020 | GW Pharma | GWPH | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 7/22/2020 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2020 | Prevail Therapeutics | PRVL | New Coverage | Buy (N/A) |
14.27 (23.00) |
61.18% | Details | |
| 7/15/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | GW Pharma | GWPH | Downgrade | Hold (Buy) |
132.19 (218.96) |
65.64% | Details | |
| 7/7/2020 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Hold) |
51.61 (48.98) |
-5.1% | Details | |
| 6/26/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2020 | Akcea Therapeutics, Inc. | AKCA | Maintain | Hold (N/A) |
|
Details | ||
| 4/30/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 4/27/2020 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2020 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 3/12/2020 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
8.57 (3.38) |
-60.56% | Details | |
| 3/10/2020 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2020 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 2/7/2020 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
69.67 (329.83) |
373.42% | Details | |
| 12/16/2019 | WAVE Life Sciences | WVE | Maintain | Hold (N/A) |
|
Details | ||
| 12/5/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2019 | WAVE Life Sciences | WVE | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2019 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 10/24/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (N/A) |
|
Details | ||
| 10/23/2019 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 10/22/2019 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 10/22/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2019 | uniQure BV | QURE | New Coverage | Buy (N/A) |
41.12 (4.54) |
-88.96% | Details | |
| 10/7/2019 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2019 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 9/3/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 8/30/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 8/19/2019 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (N/A) |
|
Details | ||
| 7/15/2019 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2019 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2019 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (N/A) |
|
Details | ||
| 4/25/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 4/16/2019 | WAVE Life Sciences | WVE | Downgrade | Hold (Buy) |
34.02 (4.74) |
-86.07% | Details | |
| 4/15/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2019 | Zogenix, Inc. | ZGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2019 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
9.42 (40.10) |
325.69% | Details | |
| 3/21/2019 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 3/1/2019 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Biogen | BIIB | Downgrade | Hold (Buy) |
335.16 (267.87) |
-20.08% | Details | |
| 1/29/2019 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 12/24/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (Hold) |
|
Details | ||
| 12/4/2018 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2018 | Alkermes | ALKS | Maintain | Hold (N/A) |
|
Details | ||
| 10/15/2018 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
17.35 (10.49) |
-39.54% | Details | |
| 10/5/2018 | Acorda Therapeutics, Inc. | ACOR | Maintain | Hold (Hold) |
|
Details | ||
| 9/25/2018 | Ionis Pharmaceuticals | IONS | Maintain | Hold (N/A) |
|
Details | ||
| 9/25/2018 | Akcea Therapeutics, Inc. | AKCA | Maintain | Hold (N/A) |
|
Details | ||
| 9/24/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 9/20/2018 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 9/20/2018 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2018 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Zogenix, Inc. | ZGNX | New Coverage | Buy (N/A) |
49.70 (26.68) |
-46.32% | Details | |
| 8/15/2018 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
132.18 (132.19) |
0.01% | Details | |
| 8/13/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details |
